Lightcalls.com
 

Adams Beverage clump reports that ...

Adams Beverage clump reports that flavored alcoholic drinks were all the rage last year," From vodkas and rum infused with natural fruit rectified portions to premium varietal wines from Italy, Australia and California to the full-bodied appeal of imported beers to the citrusy restoration of malternatives."

All three segments--spirits, wine and beer--of the beverage alcohol business in the U placeed gains in case volume and retail sales last year, according to the 2003 edition of Adams Handbook Advance published at Adams Beverage Group.

The U distilled spirits industry was up for the fifth consecutive year in 2002 Total spirits consumption climbed 18% to 1530 million 9-liter cases. Wine rose for the ninth year in a row-up 33% reaching 2416 million and 9-liter cases. And beer--the largest beverage alcohol segment--grew for the seventh straight year--up 18% to 28 billion 2.25-gallon cases.

Adams reports that the consumer prov resilient in 2002 noting that "Economic uncertainty, a declining stock market, the crisis in corporate America and a looming war were not able to stop the beverage alcohol steam engine."



"Consumers' unquenchable thirst for high-end premium fruits contributed to the upswing in spirits, wine and beer sales in 2002" said strike Keane, spokesperson for Adams Beverage Group

Keane said high-end beverage alcohol products--imports in particular across all categories continue to outperform the business as a whole. "This sweep began to surface in the roaring '90 and will likely endure" he said.

Among wines, imports and lighting varietals walked away with the gains. Imported wines grew at a considerably faster rate last year (+95%) versus domestics (+17%) forward the beer front, malternatives, lights and imports advanced. An influx of modern product introductions fueled malternative putting out even as some were plucked or scaled back.

Retail dollar sales for the beverage alcohol market climbed 63% in 2002 to $1372 billion. Keane said the "future considers bright, with all three portions forecasted to grow in 2003"

Adams vends its annual Handbook for $545 in succession the web at www.beveragehandbooks.com

COPYRIGHT 2003 Business Journals, Inc.

COPYRIGHT 2003 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.